While deal value for VC med tech investments trended upward last quarter, deal volume slumped, according to a recent PitchBook report.
Why it matters: The discrepancy is a reflection that venture funding is harder to come by as VC investors prioritize higher-quality investments, according to PitchBook analyst Aaron DeGagne.
